RaQualia Pharma Inc. (TSE:4579) agreed to acquire FIMECS, Inc. from Nissay Capital No. 11 Investment Limited Partnership and Nissay Capital Co., Ltd. for ¥4.5 billion on February 14, 2024. The transaction is expected to close on March 26, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
569 JPY | -3.40% | -4.85% | -17.30% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.30% | 81.67M | |
+37.51% | 705B | |
+32.42% | 583B | |
-3.06% | 364B | |
+20.49% | 332B | |
+5.73% | 291B | |
+16.60% | 238B | |
-3.44% | 210B | |
+10.45% | 209B | |
+9.43% | 169B |
- Stock Market
- Equities
- 4579 Stock
- News RaQualia Pharma Inc.
- RaQualia Pharma Inc. agreed to acquire FIMECS, Inc. from Nissay Capital No. 11 Investment Limited Partnership and Nissay Capital Co., Ltd. for ¥4.5 billion.